Journal
CURRENT PSYCHIATRY REPORTS
Volume 14, Issue 5, Pages 478-485Publisher
SPRINGER
DOI: 10.1007/s11920-012-0299-2
Keywords
Mental health and addictive disorders; Nicotine dependence; Tobacco; Treatment; Smoking cessation; Psychiatric disorders; Schizophrenia; Anxiety disorders; Mood disorders; Substance use disorders; Alcoholism; Comorbidities; Pharmacotherapy; Integrated care
Categories
Funding
- National Institute on Drug Abuse (NIDA) [2U01-DA-020830-07, R03-DA027052]
- Canadian Institutes of Health Research (CIHR) [115145]
- Ontario Mental Health Foundation
- Pfizer
- AstraZeneca
- Janssen-Ortho
- Taylor Francis
Ask authors/readers for more resources
People with mental health and addictive disorders (MHADs) have higher rates of cigarette smoking, and less success in quitting smoking compared with the general population. Moreover, tobacco-related medical illness may be the leading cause of death in the MHAD population. We discuss the scope of this comorbidity, and approaches to the treatment of tobacco dependence in people with MHAD, including schizophrenia, mood disorders, anxiety disorders, and alcohol and substance use disorders. Finally, at the level of health systems, we emphasize the importance of integrated treatment of tobacco dependence in MHADs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available